TickerFactsScreenerDevelopers

Lyra Therapeutics, Inc. (LYRA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$13.75M2020: -$21.14M2021: -$25.82M2022: -$43.38M2023: -$63.30M2024: -$70.01M2025: -$28.86M-$28.86M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$28.86M+58.8%
2024-$70.01M-10.6%
2023-$63.30M-45.9%
2022-$43.38M-68.0%
2021-$25.82M-22.1%
2020-$21.14M-53.7%
2019-$13.75M—